Plain-English translation of NCT05720338 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
When surgeons remove part of the pancreas (called distal pancreatectomy), they sometimes place a small drain inside the abdomen to collect fluid and help prevent infections. This trial is testing whether that drain is actually necessary. Researchers will compare two groups: one that receives the drain as normal, and one that does not, to see which approach leads to fewer complications.
Pancreas surgery carries a high risk of complications like infections and fluid buildup. Surgeons traditionally use drains to manage these risks, but newer surgical techniques may make the drain unnecessary. This trial aims to find out whether skipping the drain is safe, which could mean less discomfort and faster recovery for patients.
You likely qualify if…
You likely don't qualify if…
You will undergo distal pancreatectomy surgery as planned. Before the operation, you will be randomly assigned to either receive a drainage tube after surgery (standard care) or to have no drain placed. After surgery, you will be monitored for complications like infections or fluid collection. The study tracks your recovery and compares outcomes between the two groups to determine if the drain makes a meaningful difference in preventing problems.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States
Phase
Large-scale testing
Sponsor
Case Comprehensive Cancer Center
Enrollment target
~234 participants
Started
April 2023
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Robert Simon, MD
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.